The SHAP-CLB system effectively inhibited Aβ self-assembly, protected cells from inflammation-induced damage, improved locomotor activity in rats with induced AD, and reduced inflammation levels in brain tissues. This evidence concerns the gene CLYBL and Alzheimer disease.